233 related articles for article (PubMed ID: 16595353)
1. Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial.
Sullivan MA; Rothenberg JL; Vosburg SK; Church SH; Feldman SJ; Epstein EM; Kleber HD; Nunes EV
Am J Addict; 2006; 15(2):150-9. PubMed ID: 16595353
[TBL] [Abstract][Full Text] [Related]
2. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD
Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538
[TBL] [Abstract][Full Text] [Related]
3. Behavioral naltrexone therapy: an integrated treatment for opiate dependence.
Rothenberg JL; Sullivan MA; Church SH; Seracini A; Collins E; Kleber HD; Nunes EV
J Subst Abuse Treat; 2002 Dec; 23(4):351-60. PubMed ID: 12495797
[TBL] [Abstract][Full Text] [Related]
4. Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone.
Sullivan MA; Bisaga A; Glass A; Mishlen K; Pavlicova M; Carpenter KM; Mariani JJ; Levin FR; Nunes EV
Drug Alcohol Depend; 2015 Feb; 147():122-9. PubMed ID: 25555621
[TBL] [Abstract][Full Text] [Related]
5. Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence.
Aklin WM; Severtson SG; Umbricht A; Fingerhood M; Bigelow GE; Lejuez CW; Silverman K
J Clin Psychiatry; 2012 Aug; 73(8):e1056-61. PubMed ID: 22967782
[TBL] [Abstract][Full Text] [Related]
6. Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
Psychol Addict Behav; 2012 Mar; 26(1):145-50. PubMed ID: 21859169
[TBL] [Abstract][Full Text] [Related]
7. Rationale for maintenance pharmacotherapy of opiate dependence.
Kreek MJ
Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
[TBL] [Abstract][Full Text] [Related]
8. Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence.
Carreño JE; Alvarez CE; Narciso GI; Bascarán MT; Díaz M; Bobes J
Addict Biol; 2003 Dec; 8(4):429-38. PubMed ID: 14690879
[TBL] [Abstract][Full Text] [Related]
9. Experiences with an outpatient relapse program (community reinforcement approach) combined with naltrexone in the treatment of opioid-dependence: effect on addictive behaviors and the predictive value of psychiatric comorbidity.
Roozen HG; Kerkhof AJ; van den Brink W
Eur Addict Res; 2003 Apr; 9(2):53-8. PubMed ID: 12644730
[TBL] [Abstract][Full Text] [Related]
10. Improvement in naltrexone treatment compliance with contingency management.
Preston KL; Silverman K; Umbricht A; DeJesus A; Montoya ID; Schuster CR
Drug Alcohol Depend; 1999 Apr; 54(2):127-35. PubMed ID: 10217552
[TBL] [Abstract][Full Text] [Related]
11. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients.
Backmund M; Meyer K; Eichenlaub D; Schütz CG
Drug Alcohol Depend; 2001 Oct; 64(2):173-80. PubMed ID: 11543987
[TBL] [Abstract][Full Text] [Related]
12. Does naltrexone affect craving in abstinent opioid-dependent patients?
Dijkstra BA; De Jong CA; Bluschke SM; Krabbe PF; van der Staak CP
Addict Biol; 2007 Jun; 12(2):176-82. PubMed ID: 17508990
[TBL] [Abstract][Full Text] [Related]
13. [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
Poser W; Ehrenreich H
Internist (Berl); 1996 Oct; 37(10):1061-7; discussion 1067. PubMed ID: 9019453
[No Abstract] [Full Text] [Related]
14. A study of the use of clonidine and naltrexone in the treatment of opioid addiction in the former USSR.
Azatian A; Papiasvilli A; Joseph H
J Addict Dis; 1994; 13(1):35-52. PubMed ID: 8018739
[TBL] [Abstract][Full Text] [Related]
15. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.
Carroll KM; Ball SA; Nich C; O'Connor PG; Eagan DA; Frankforter TL; Triffleman EG; Shi J; Rounsaville BJ
Arch Gen Psychiatry; 2001 Aug; 58(8):755-61. PubMed ID: 11483141
[TBL] [Abstract][Full Text] [Related]
16. Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China.
Hser YI; Li J; Jiang H; Zhang R; Du J; Zhang C; Zhang B; Evans E; Wu F; Chang YJ; Peng C; Huang D; Stitzer ML; Roll J; Zhao M
Addiction; 2011 Oct; 106(10):1801-9. PubMed ID: 21793958
[TBL] [Abstract][Full Text] [Related]
17. Increasing opiate abstinence through voucher-based reinforcement therapy.
Silverman K; Wong CJ; Higgins ST; Brooner RK; Montoya ID; Contoreggi C; Umbricht-Schneiter A; Schuster CR; Preston KL
Drug Alcohol Depend; 1996 Jun; 41(2):157-65. PubMed ID: 8809505
[TBL] [Abstract][Full Text] [Related]
18. Naltrexone for heroin dependence treatment in St. Petersburg, Russia.
Krupitsky EM; Zvartau EE; Masalov DV; Tsoi MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
J Subst Abuse Treat; 2004 Jun; 26(4):285-94. PubMed ID: 15182893
[TBL] [Abstract][Full Text] [Related]
19. Methadone maintenance and recovery from opioid dependence.
Maddux JF; Desmond DP
Am J Drug Alcohol Abuse; 1992; 18(1):63-74. PubMed ID: 1562007
[TBL] [Abstract][Full Text] [Related]
20. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
Stimmel B
J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922
[No Abstract] [Full Text] [Related]
[Next] [New Search]
